Esilida Sula Karreci, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lisinopril | 1 | 2024 | 61 | 0.940 |
Why?
|
Glucosides | 1 | 2024 | 512 | 0.670 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 916 | 0.580 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1516 | 0.580 |
Why?
|
Granzymes | 1 | 2017 | 277 | 0.520 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9542 | 0.390 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1321 | 0.350 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 3080 | 0.280 |
Why?
|
Graft Survival | 1 | 2016 | 3820 | 0.260 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18255 | 0.240 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4176 | 0.220 |
Why?
|
Heart Transplantation | 1 | 2016 | 3233 | 0.210 |
Why?
|
Apolipoproteins | 1 | 2024 | 326 | 0.200 |
Why?
|
Proteinuria | 1 | 2024 | 607 | 0.190 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2024 | 335 | 0.180 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 676 | 0.170 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2018 | 112 | 0.150 |
Why?
|
Serpins | 1 | 2017 | 247 | 0.130 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.130 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 1229 | 0.100 |
Why?
|
Immunophenotyping | 1 | 2017 | 1869 | 0.100 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22174 | 0.100 |
Why?
|
Cell Proliferation | 2 | 2018 | 10451 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2016 | 1359 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1844 | 0.080 |
Why?
|
Immune Tolerance | 1 | 2018 | 2302 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7048 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8481 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6214 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3617 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2016 | 2747 | 0.060 |
Why?
|
Mice | 3 | 2024 | 81539 | 0.060 |
Why?
|
Graft Rejection | 1 | 2017 | 4446 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17904 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4235 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7396 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9490 | 0.050 |
Why?
|
Animals | 3 | 2024 | 168475 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5146 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16990 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10194 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 243 | 0.040 |
Why?
|
Antibodies, Neoplasm | 1 | 2018 | 281 | 0.030 |
Why?
|
Humans | 3 | 2024 | 761596 | 0.020 |
Why?
|
Male | 1 | 2024 | 360846 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15601 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14417 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23447 | 0.010 |
Why?
|